Cenupatide

Cenupatide is an urokinase plasminogen activator receptor (uPAR) inhibitor drug candidate. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of streptozotocin (STZ)-induced diabetes. Cenupatide was found to revert STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression suggesting that the drug may act downstream uPAR, and recovered the increased activity of the αvβ3 integrin/Rac-1 pathway indicating a major role of uPAR in regulating podocyte function.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	R1917
Chemical Structure
CAS	1006388-38-0
Chemical Name	(2S)-2-acetamido-N-[1-[[(2S)-1-[[(2S)-1-amino-2-methyl-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]-5-(diaminomethylideneamino)pentanamide
M.F/Formula	C28H47N11O5
M.W/Mr.	617.76
Sequence	One Letter Code: RXRX Three Letter Code: Ac-Arg-Aib-Arg-aMePhe-NH2
Application	Solid powder
Biological Activity	Cenupatide is an urokinase plasminogen activator receptor (uPAR) inhibitor for treating disorders associated altered cell migration, such as cancer.

Storage	Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility	Soluble in DMSO
Shipping Condition	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
InChI	InChI=1S/C28H47N11O5/c1-17(40)36-19(12-8-14-34-25(30)31)21(41)38-27(2,3)24(44)37-20(13-9-15-35-26(32)33)22(42)39-28(4,23(29)43)16-18-10-6-5-7-11-18/h5-7,10-11,19-20H,8-9,12-16H2,1-4H3,(H2,29,43)(H,36,40)(H,37,44)(H,38,41)(H,39,42)(H4,30,31,34)(H4,32,33,35)/t19-,20-,28-/m0/s1
InChI Key	JDNFBDNDFFJJIB-JVAKCPTJSA-N
Canonical SMILES	CC(=O)NC(CCCN=C(N)N)C(=O)NC(C)(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)(CC1=CC=CC=C1)C(=O)N
Isomeric SMILES	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NC(C)(C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@](C)(CC1=CC=CC=C1)C(=O)N

CAT#	Product Name	M.W	Molecular Formula	Inquiry
R1309	Crustacean Cardioactive Peptide CCAP			Inquiry
R0869	BIM 189			Inquiry
R1925	COG-1410			Inquiry
R1386	Glucagon-like peptide 1 (1-37), human			Inquiry
R1239	BMf-BH3			Inquiry

Write a review Ask a question

My Review for Cenupatide

Required fields are marked with *

• Review Headline *
• Comments *
• Basic Information
• Name
• Email *
• Phone
• Submit

×

Ask a Question for Cenupatide

Required fields are marked with *

• Question *
• Basic Information
• Name
• Email *
• Phone
• Submit

×

Peptide Calculator

Abbreviation List

Peptide Glossary

Purity

Technical Support

Peptide Guide

FAQ

1. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII